China Resources Pharmaceutical Group Limited
CRPGF
$0.5414
$0.54140.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.14% | -35.63% | -6.01% | -7.43% | 39.98% |
| Total Depreciation and Amortization | 6.13% | 6.98% | 3.00% | 1.44% | 41.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.78% | 18.72% | 10.00% | 8.33% | 21.65% |
| Change in Net Operating Assets | -7.09% | -6.35% | 21.58% | 22.76% | 43.46% |
| Cash from Operations | -3.60% | -2.83% | 73.82% | 74.22% | 38.88% |
| Capital Expenditure | -14.61% | -15.52% | 9.78% | 11.14% | -24.72% |
| Sale of Property, Plant, and Equipment | -20.39% | -19.76% | 148.42% | 144.65% | 136.25% |
| Cash Acquisitions | -394.68% | -398.62% | -135.42% | -134.88% | -1,156.35% |
| Divestitures | -107.22% | -107.28% | -- | -- | 157.26% |
| Other Investing Activities | -195.44% | -197.80% | -585.90% | -578.55% | -148.11% |
| Cash from Investing | -133.10% | -134.96% | -1,341.60% | -1,322.82% | -470.58% |
| Total Debt Issued | 1.04% | 1.04% | -11.02% | -11.02% | 35.86% |
| Total Debt Repaid | 3.80% | 3.80% | -1.34% | -1.34% | -32.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -69.84% | -71.19% | -- | -- | -6.51% |
| Other Financing Activities | -1,566.45% | -1,566.45% | -168.65% | -168.65% | 3,980.96% |
| Cash from Financing | -32.15% | -33.20% | -80.18% | -80.48% | 5.28% |
| Foreign Exchange rate Adjustments | -13,342.79% | -13,406.98% | -40.59% | -41.48% | -99.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -327.72% | -329.54% | -133.36% | -132.86% | 2,568.16% |